FDA Approves New Drug for Deadly Lung Cancer

The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer.

Importantly, tarlatamab (Imdelltra) is only for patients who have exhausted all other options to treat extensive-stage small cell lung cancer.

"The FDA's approval of Imdelltra marks a pivotal...

U.S. Justice Department Moves to Reclassify Weed as Less Risky Drug

The U.S. Justice Department on Thursday moved to reclassify marijuana as a less dangerous drug, setting the stage for a significant shift in the nation's drug policy.

In a proposed rule sent to the federal register, officials acknowledge the medical uses of marijuana and state that cannabis has less potential for abuse than more dangerous ...

Global Life Expectancy Could Rise By More Than 4 Years by 2050

Life expectancy around the world is expected to increase by nearly 5 years in men and more than 4 years in women during the next three decades, researchers predict.

These increases are expected to be in countries where life expectancy typically is shorter, according to the report published May 16 in The Lancet.

The trend is ...

Most Cancer Treatments Near End of Life Are Useless: Study

Cutting-edge cancer treatments are essentially useless for patients barely clinging to life, a new study shows.

Chemotherapies, immunotherapies, targeted therapies and hormone therapies do not improve survival rates in patients with very advanced tumors near the end of life, according to findings published May 16 in the journal JAMA On...